Monoclonal Gammopathy of Undetermined Significance and Bone Health Outcomes: A Systematic Review and Exploratory Meta-Analysis

Journal of Bone and Mineral Metabolism - Japan
doi 10.1007/s00774-017-0817-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Monoclonal Gammopathy of Undetermined Significance

English

Prior Autoimmune Disease and Risk of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma: A Systematic Review

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2014English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Hematology/Oncology Clinics of North America
OncologyHematology
2007English

Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2010English

Concurrent Mastocytosis and Monoclonal Gammopathy of Undetermined Significance, a Case Series

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Prevention of Progression in Monoclonal Gammopathy of Undetermined Significance

Clinical Cancer Research
Cancer ResearchOncology
2009English

Determining the Clinical Significance of Monoclonal Gammopathy of Undetermined Significance: A SEER–Medicare Population Analysis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Gamma-Heavy Chain Monoclonal Gammopathy With Undetermined Significance (MGUS)

Journal of clinical and experimental hematopathology : JCEH
Medicine
2019English

Monoclonal Gammopathy of Undetermined Significance and Risk of Infections: A Population-Based Study

Haematologica
Hematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy